Remote monitoring

On July 3, 2025, the UK Government published the 10 Year Health Plan for England as part of its mission to build a health service fit for the future. It sets out how the government will reinvent the NHS through three radical shifts - hospital to community, analogue to digital, and sickness to prevention. This transition will be supported by a new NHS operating model, improved transparency of care quality, a redesigned workforce model, innovation to power transformation, and a new financial foundation. Five transformative technologies will drive reform: data, AI, genomics, wearables, and robotics. Other MedTech-related initiatives include expanding NICE's technology appraisals to devices, diagnostics, and digital products and implementing the 'Innovator passport'.

In December 2024, the National Institute for Health and Disability Insurance (INAMI/RIZIV) launched a new agreement (Convention) allowing reimbursement for remote monitoring of patients with chronic heart failure. It will come into force on January 1, 2025. New codes (pseudonomenclature) with fees for packages of care will be used for reimbursement. The packages include monitoring of clinical parameters by patients at home (e.g., blood pressure measurement or pulmonary artery pressure measured by an implanted sensor) and transmission of data via a health app to the remote monitoring team at the hospital.

The Danish Health Data Authority quarterly updates the Health Care Classification System (SKS). The updated version was published in mid-September 2024 to come into force on October 1, 2024. Eight new medical procedure codes and one new code for diagnostic investigations were introduced concerning obstetrics and gynecology, extracorporeal treatments, spine, cardiovascular, e-health, diagnostic imaging, and some other fields.

In July 2024, the National Institute for Health and Care Research (NIHR) in England released five MedTech-related assessments in its Health Technology Assessment (HTA) Journal, which concerned cloud-based device (CaRi-Heart) for predicting cardiac risk, remote continuous monitoring of Parkinson's disease, home-monitoring for neovascular age-related macular degeneration, treatment of pilonidal sinus disease, and cystatin C in glomerular filtration rate-estimating. HTA Journal publishes research reports on the effectiveness, costs, and broader impact of health technologies for those who use, manage, and provide care in the NHS and informs National Institute for Health and Care Excellence (NICE) guidance.

In the second quarter of 2024, the Dutch Healthcare Institute (ZIN) published four coverage positions on proton therapy in testicular cancer, pulmonary artery pressure remote monitoring in chronic heart failure and neuromodulation in polyneuropathy with positive recommendation for coverage under basic insurance package, and on physiotherapy and exercise therapy in primary care settings for lower back pain, which was not recommended for coverage under the basic insurance package.

On June 10, 2024, the National Agency for Regional Health Services (AGENAS) announced an online public consultation on the draft of the “Guidelines on the Evolutionary Pathway of Medical Systems for Telemonitoring”.

The HTA body of the Tuscany Regional Healthcare issues three types of documents: full HTA reports, rapid HTA reports, and motivational forms. With regional decree 8521 of April 19, 2024, Tuscany Regional Healthcare published three reassessments of medical devices in the cardiovascular, peripheral vascular, and e-health areas.

In February 2024, the Basque Office for Health Technology Assessment (OSTEBA) is working on several HTAs, including evaluations in the cardiovascular, e-health, ENT, IVD, and some other fields.

In January 2024, the National Institute for Health and Care Excellence (NICE) published three new Interventional Procedure Guidance (intravascular lithotripsy in peripheral arterial disease, temperature control after cardiac arrest, and pharyngeal electrical stimulation for neurogenic dysphagia) and one new Diagnostics Guidance (AI-derived software to help clinical decision making in stroke). Furthermore, one Diagnostics Guidance and five clinical guidelines were updated.

In the fourth quarter of 2023, two new health technology assessments were initiated by the Agency for Health Technology Assessment and Tariff System (AOTMiT). The assessments belong to the cardiovascular and neurovascular technology groups.

In October 2023, the National Institute for Health and Care Excellence (NICE) published two new Interventional Procedure Guidance (percutaneous deep venous arterialisation, vaginal transluminal endoscopic hysterectomy and adnexal surgery) and two Health Technology Evaluations using early value assessment (digital technologies for delivering specialist weight-management services, virtual ward platform technologies for acute respiratory infections). Also, one new clinical guideline was published, and eight were updated.

In late October 2023, the Basque Office for Health Technology Assessment (OSTEBA) is working on several HTAs, including the evaluations in the cardiovascular, diagnostic imaging, e-health, ENT, ICU/OR, nephrology and urology, IVD, neurovascular, obstetrics and gynecology, surgical procedures, and some other fields.